Orchid Cellmark News (NASDAQ:ORCH)
| Latest Orchid Cellmark News Headlines | | Date | Time | Source | | | 07/16/2008 | 7:00AM | PRNUS | Florida's Department of Revenue Upholds Contract Award to Orchid Cellmark for Multi-Year Paternity Testing
- POTENTIAL CONTRACT VALUE OF $1.2 MILLION ANNUALLY -
PRINCETON, N.J., July 16 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today announced that the State of Florida's Department of Revenue has upheld the contract award to the company to... More...>> |
| 06/11/2008 | 7:00AM | PRNUS | Orchid Cellmark Launches New Paternity and DNA Testing Web Site
- www.orchidcellmark.com -
PRINCETON, N.J., June 11 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today announced the launch of a new paternity and DNA testing web site at http://www.orchidcellmark.com/. This new user-friendly web site allows... More...>> |
| 05/27/2008 | 7:00AM | PRNUS | Orchid Cellmark Appoints Jeffrey S. Boschwitz as Vice President, North America Marketing & Sales
PRINCETON, N.J., May 27 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today announced a change in its sales and marketing organization.
Jeffrey S. Boschwitz, Ph.D. has been appointed Vice President of North America Marketing and Sales... More...>> |
| 05/12/2008 | 7:00AM | PRNUS | Orchid Cellmark to Present at the 2008 Bank of America Health Care Conference
PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH) today announced that Thomas A. Bologna, President and Chief Executive Officer of Orchid, is scheduled to present at the 2008 Bank of America Health Care Conference in Las Vegas on Wednesday, May 14, 2008 at 3:20 p.m. PDT.
Mr. Bologna... More...>> |
| 05/08/2008 | 7:00AM | PRNUS | Orchid Cellmark Reports First Quarter 2008 Financial Results
- U.S. Business Shows 21% Increase in Revenues and Notable Improvement in Gross Margin -
PRINCETON, N.J., May 8 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today reported its financial results for the first quarter of 2008.
Total revenues... More...>> |
| 05/01/2008 | 7:00AM | PRNUS | Orchid Cellmark to Announce First Quarter 2008 Financial Results on May 8, 2008
PRINCETON, N.J., May 1 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, will release its first quarter 2008 financial results on Thursday, May 8, 2008 at approximately 7:00 a.m. EDT, and is hosting a conference call and webcast to discuss the... More...>> |
| 04/30/2008 | 7:00AM | PRNUS | Orchid Cellmark Signs Contracts to Provide Forensic Services for U.K. Police Forces Under Newly-Awarded Regional Forensic Tender
- As a Result of its Success in the North West/South West and Wales Regional Tender, the Company Has Begun Providing the Police with Forensic Services That Have a Potential Value of $10 Million Annually -
PRINCETON, N.J., April 30 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider... More...>> |
| 04/21/2008 | 7:00AM | PRNUS | Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services
- New Facility to be Opened in the North West of England -
PRINCETON, N.J., April 21 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today announced that it will open a new regional forensic facility in the North West of England later this... More...>> |
| 04/18/2008 | 7:00AM | PRNUS | Orchid Cellmark Applauds Expansion of Federal Forensic DNA Identity Testing to Include All Arrestees
- New Federal Rules Authorizing DNA Testing of Federal Arrestees Expected to Boost Law Enforcement's Ability to Combat Crime -
PRINCETON, N.J., April 18 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today highlighted new federal regulations... More...>> |
| 03/06/2008 | 7:00AM | PRNUS | Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results
PRINCETON, N.J., March 6 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today reported its financial results for the fourth quarter and full year of 2007.
Total revenues were essentially flat at $15.0 million for the fourth quarter of 2007... More...>> |
| 02/29/2008 | 3:45PM | PRNUS | Orchid Cellmark to Announce Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
PRINCETON, N.J., Feb. 29 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, will release its fourth quarter and full year 2007 financial results on Thursday, March 6, 2008 at approximately 7:00 am EST, and is hosting a conference call and webcast... More...>> |
| 11/20/2007 | 7:00AM | PRNUS | Orchid Cellmark Appoints William J. Thomas Vice President and General Counsel
PRINCETON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today announced the appointment of William J. Thomas, Esq. as Vice President and General Counsel.
Mr. Thomas was formerly Senior Vice President and General Counsel for... More...>> |
| 11/01/2007 | 7:00AM | PRNUS | Orchid Cellmark Reports Third Quarter 2007 Financial Results
-Operating Loss Decreases by 27% Compared to the Third Quarter of 2006-
PRINCETON, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today reported its financial results for the third quarter of 2007.
Total revenues were $15.6 million... More...>> |
| 10/31/2007 | 4:06PM | PRNUS | Orchid Cellmark Announces Closing of Acquisition of Reliagene Technologies, Inc.
PRINCETON, N.J., Oct. 31 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today announced that it has closed the previously announced transaction to acquire the outstanding stock of ReliaGene Technologies, Inc. for a purchase price of $5.6 million... More...>> |
| 10/22/2007 | 4:06PM | PRNUS | Orchid Cellmark to Purchase ReliaGene Technologies, Inc.
PRINCETON, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today announced that it has signed a definitive purchase agreement to acquire the outstanding stock of ReliaGene Technologies, Inc. for a purchase price of $5.6 million... More...>> |
| 10/15/2007 | 7:00AM | PRNUS | Orchid Cellmark to Announce Third Quarter 2007 Financial Results on November 1, 2007
PRINCETON, N.J., Oct. 15 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, will release its third quarter 2007 financial results on Thursday, November 1, 2007 at approximately 7:00 am EDT, and is hosting a conference call and webcast to discuss... More...>> |
| 10/09/2007 | 7:00AM | PRNUS | Orchid Cellmark Appoints James F. Smith Chief Financial Officer
PRINCETON, N.J., Oct. 9 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today announced the appointment of James F. Smith as Vice President and Chief Financial Officer. Mr. Smith will report directly to Thomas A. Bologna, Orchid Cellmark's... More...>> |
| 08/02/2007 | 7:00AM | PRNUS | Orchid Cellmark Reports Second Quarter 2007 Financial Results
Revenues Increase by 16% and Operating Loss Decreases by 83% Compared to the Second Quarter of 2006
PRINCETON, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today reported its financial results for the second quarter of 2007.
Total... More...>> |
| 07/26/2007 | 7:00AM | PRNUS | Orchid Cellmark to Announce Second Quarter 2007 Financial Results on August 2, 2007
PRINCETON, N.J., July 26 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, will release its second quarter 2007 financial results on Thursday, August 2, 2007 at approximately 7:00 am EDT, and is hosting a conference call and webcast to discuss... More...>> |
| 07/10/2007 | 9:58AM | PRNUS | Orchid Cellmark's Forensic DNA Testing Services Aid in Exoneration of New Jersey Man Wrongfully Convicted of Brutal Rape and Mur
-Pro Bono Laboratory Services Supplied to the Innocence Project Help in Freeing Another Wrongfully Convicted Individual After Years of Incarceration-
PRINCETON, N.J., July 10 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, today announced that... More...>> |
|
|
|